---All---
  • ---All---
  • Accession
  • Catalog #

Phospho-PDX1-T11 Antibody Blocking PeptideSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP3669a 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

Phospho-PDX1-T11 Antibody Blocking Peptide - Product info

Primary AccessionP52945
Other AccessionNP_000200
Clone Names80118176
Calculated MW30771 Da

Phospho-PDX1-T11 Antibody Blocking Peptide - Additional info

Gene ID 3651
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP3669a was selected from the region of human Phospho-PDX1-T11. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Format
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

Phospho-PDX1-T11 Antibody Blocking Peptide - Protein Information

Name PDX1
Synonyms IPF1, STF1
Function
Activates insulin, somatostatin, glucokinase, islet amyloid polypeptide and glucose transporter type 2 gene transcription. Particularly involved in glucose-dependent regulation of insulin gene transcription. As part of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells is involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element. Binds preferentially the DNA motif 5'-[CT]TAAT[TG]-3' During development, specifies the early pancreatic epithelium, permitting its proliferation, branching and subsequent differentiation. At adult stage, required for maintaining the hormone-producing phenotype of the beta-cell
Cellular Location
Nucleus. Cytoplasm, cytosol (By similarity).
Tissue Location
Duodenum and pancreas (Langerhans islet beta cells and small subsets of endocrine non-beta-cells, at low levels in acinar cells)

Phospho-PDX1-T11 Antibody Blocking Peptide - Related products

AP3617a: Phospho-IPF-pT11 Antibody

AP3618a: Phospho-IPF-pS66 Antibody

AP3669a: Phospho-PDX1-T11 Antibody

AP7740a: PDX1 Antibody (N-term)

AP7740b: IPF Antibody (C-term)

AP7740d: IPF Antibody (T11)

AP7740e: IPF Antibody (S66)

RI13902: PDX1 predesign siRNA

BP3617a: Phospho-IPF-pT11 Antibody Blocking Peptide

BP3618a: Phospho-IPF-pS66 Antibody Blocking Peptide

BP3669a: Phospho-PDX1-T11 Antibody Blocking Peptide

BP7740a: IPF Antibody (N-term) Blocking Peptide

BP7740b: IPF Antibody (C-term) Blocking Peptide

BP7740d: IPF Antibody (T11) Blocking Peptide

BP7740e: IPF Antibody (S66) Blocking Peptide

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

PDX1 is a transcriptional activator of several genes, including insulin, somatostatin, glucokinase, islet amyloid polypeptide, and glucose transporter type 2. The encoded nuclear protein is involved in the early development of the pancreas and plays a major role in glucose-dependent regulation of insulin gene expression. Defects in this protein are a cause of pancreatic agenesis, which can lead to early-onset insulin-dependent diabetes mellitus (NIDDM), as well as maturity onset diabetes of the young type 4 (MODY4).

REFERENCES

Nicolino,M., et.al., Diabetes 59 (3), 733-740 (2010)Cai,J., et.al., J Mol Cell Biol 2 (1), 50-60 (2010)